iocanlidic acid I-123

N/A

Report date: 2025/12/01 17:52:12
NME

Base Information

Drug Nameiocanlidic acid I-123
Drug Alias NameI123-IPPA
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agent +[4
Mechanisms of ActionRadionuclide imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsCoronary Artery Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKing Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKing Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsCoronary Artery Disease

Other Information

ATC CodeN/A
Related LinksKEGG